Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Banerjee Subhashis, holds the title of Chief Medical Officer at Artiva Biotherapeutics, Inc..
On 2026-11-17, the insider transacted 4,037 shares.The shares were transacted at a weighted average price of $3.91 per share, resulting in a total market-relevant value of $16K.
Banerjee Subhashis (Chief Medical Officer) sold $16K of $ARTV
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.